These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 8030684
1. A randomized, controlled trial of antepartum thyrotropin-releasing hormone and betamethasone in the prevention of respiratory disease in preterm infants. Knight DB, Liggins GC, Wealthall SR. Am J Obstet Gynecol; 1994 Jul; 171(1):11-6. PubMed ID: 8030684 [Abstract] [Full Text] [Related]
2. Antenatal thyrotropin-releasing hormone to prevent lung disease in preterm infants. North American Thyrotropin-Releasing Hormone Study Group. Ballard RA, Ballard PL, Cnaan A, Pinto-Martin J, Davis DJ, Padbury JF, Phibbs RH, Parer JT, Hart MC, Mannino FL, Sawai SK. N Engl J Med; 1998 Feb 19; 338(8):493-8. PubMed ID: 9468465 [Abstract] [Full Text] [Related]
3. Collaborative trial of prenatal thyrotropin-releasing hormone and corticosteroids for prevention of respiratory distress syndrome. Collaborative Santiago Surfactant Group. Am J Obstet Gynecol; 1998 Jan 19; 178(1 Pt 1):33-9. PubMed ID: 9465799 [Abstract] [Full Text] [Related]
4. Respiratory disease in very-low-birthweight infants after prenatal thyrotropin-releasing hormone and glucocorticoid. TRH Study Group. Ballard RA, Ballard PL, Creasy RK, Padbury J, Polk DH, Bracken M, Moya FR, Gross I. Lancet; 1992 Feb 29; 339(8792):510-5. PubMed ID: 1346877 [Abstract] [Full Text] [Related]
8. Thyrotropin-releasing hormone added to corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. Crowther CA, Alfirevic Z, Haslam RR. Cochrane Database Syst Rev; 2004 Aug 29; (2):CD000019. PubMed ID: 15106139 [Abstract] [Full Text] [Related]
9. Fetal lung maturation: the combined use of corticosteroids and thyrotropin-releasing hormone. Morales WJ, O'Brien WF, Angel JL, Knuppel RA, Sawai S. Obstet Gynecol; 1989 Jan 29; 73(1):111-6. PubMed ID: 2491766 [Abstract] [Full Text] [Related]
13. Plasma thyroid hormones and prolactin in premature infants and their mothers after prenatal treatment with thyrotropin-releasing hormone. Ballard PL, Ballard RA, Creasy RK, Padbury J, Polk DH, Bracken M, Moya FR, Gross I. Pediatr Res; 1992 Dec 08; 32(6):673-8. PubMed ID: 1287557 [Abstract] [Full Text] [Related]
14. The effect of corticosteroid therapy in the very premature infant. March of Dimes Multicenter Study Group. Maher JE, Cliver SP, Goldenberg RL, Davis RO, Copper RL. Am J Obstet Gynecol; 1994 Mar 08; 170(3):869-73. PubMed ID: 8141218 [Abstract] [Full Text] [Related]
15. [Prevention of respiratory distress syndrome with betamethasone. Preliminary communication]. Siebert W, Meitinger C. Geburtshilfe Frauenheilkd; 1975 Feb 08; 35(2):130-3. PubMed ID: 1173572 [Abstract] [Full Text] [Related]
19. Inhaled nitric oxide in premature infants with the respiratory distress syndrome. Schreiber MD, Gin-Mestan K, Marks JD, Huo D, Lee G, Srisuparp P. N Engl J Med; 2003 Nov 27; 349(22):2099-107. PubMed ID: 14645637 [Abstract] [Full Text] [Related]
20. Effectiveness of antenatal corticosteroid administration after preterm premature rupture of the membranes. Vermillion ST, Soper DE, Bland ML, Newman RB. Am J Obstet Gynecol; 2000 Oct 27; 183(4):925-9. PubMed ID: 11035339 [Abstract] [Full Text] [Related] Page: [Next] [New Search]